Addison Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Addison Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.5K	Sell	150 -190	-56%	-$32.7K	0.01%	301
2026 Q1	$57.4K	Hold	340	–	–	0.01%	404
2025 Q4	$57.4K	Hold	340	–	–	0.01%	399
2025 Q3	$49.1K	Hold	340	–	–	0.01%	420
2025 Q2	$43K	Sell	340 -35	-9%	-$4.3K	0.01%	426
2025 Q1	$48K	Buy	375 +35	+10%	+$4.75K	0.01%	393
2024 Q4	$45K	Hold	340	–	–	0.01%	400
2024 Q3	$49.5K	Sell	340 -5	-1%	-$723	0.01%	394
2024 Q2	$47.4K	Sell	345 -5	-1%	-$667	0.02%	383
2024 Q1	$48K	Sell	350 -23	-6%	-$3.14K	0.02%	372
2023 Q4	$50.7K	Sell	373 -13	-3%	-$1.59K	0.02%	356
2023 Q3	$47.2K	Hold	386	–	–	0.02%	326
2023 Q2	$49K	Hold	386	–	–	0.02%	318
2023 Q1	$49.9K	Hold	386	–	–	0.03%	299
2022 Q4	$50.7K	Hold	386	–	–	0.03%	284
2022 Q3	$45K	Hold	386	–	–	0.03%	276
2022 Q2	$45K	Sell	386 -75	-16%	-$8.9K	0.03%	270
2022 Q1	$60K	Sell	461 -52	-10%	-$6.77K	0.03%	259
2021 Q4	$78K	Buy	513 +28	+6%	+$4.33K	0.05%	205
2021 Q3	$78K	Hold	485	–	–	0.06%	150
2021 Q2	$79K	Buy	+485	New	+$74.7K	0.06%	146
2020 Q4	$73K	Buy	+485	New	+$69.3K	0.07%	148

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Addison Advisors's IBB Position: Q2 2026 in Review

Addison Advisors reduced its iShares Biotechnology ETF (IBB) stake by 56% in Q2 2026, selling an estimated $32.7K and leaving 150 shares worth $28.5K. The position accounts for 0.01% of the portfolio, ranked #301.

Addison Advisors first reported a position in IBB in Q4 2020 and has held it in 22 quarters since. The position peaked at $79K in Q2 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Addison Advisors held 150 shares of iShares Biotechnology ETF worth $28.5K as of Q2 2026.
Addison Advisors sold 190 iShares Biotechnology ETF shares in Q2 2026, an estimated $32.7K.
iShares Biotechnology ETF made up 0.01% of Addison Advisors's portfolio in Q2 2026, its #301 holding.
Addison Advisors first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
Addison Advisors's iShares Biotechnology ETF position peaked at $79K in Q2 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.